Skip to main content
Top
Published in: Journal of General Internal Medicine 3/2020

01-12-2020 | Opioids | Perspective

Implementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety

Authors: Joseph W. Frank, MD, MPH, Amy S. B. Bohnert, PhD, MHS, Friedhelm Sandbrink, MD, Marsden McGuire, MD, MBA, Karen Drexler, MD

Published in: Journal of General Internal Medicine | Special Issue 3/2020

Login to get access

Abstract

Evidence-based treatment of opioid use disorder, the prevention of opioid overdose and other opioid-related harms, and safe and effective pain management are priorities for the Veterans Health Administration (VHA). The VHA Office of Health Services Research and Development hosted a State-of-the-Art Conference on “Effective Management of Pain and Addiction: Strategies to Improve Opioid Safety” on September 10–11, 2019. This conference convened a multidisciplinary group to discuss and achieve consensus on a research agenda and on implementation and policy recommendations to improve opioid safety for Veterans. Participants were organized into three workgroups: (1) managing opioid use disorder; (2) Long-term opioid therapy and opioid tapering; (3) managing co-occurring pain and substance use disorder. Here we summarize the implementation and policy recommendations of each workgroup and highlight important cross-cutting issues related to telehealth, care coordination, and stepped care model implementation.
Literature
2.
go back to reference Bohnert AS, Ilgen MA, Trafton JA, et al. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain. 2014;30(7):605-612.PubMed Bohnert AS, Ilgen MA, Trafton JA, et al. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain. 2014;30(7):605-612.PubMed
5.
go back to reference Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624-1645.CrossRef Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624-1645.CrossRef
6.
go back to reference Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019;380(24):2285-2287.CrossRef Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019;380(24):2285-2287.CrossRef
7.
go back to reference Frank JW, Lovejoy TI, Becker WC, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181-191.CrossRef Frank JW, Lovejoy TI, Becker WC, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181-191.CrossRef
8.
go back to reference Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Netw Open. 2019;2(6):e196373.CrossRef Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Netw Open. 2019;2(6):e196373.CrossRef
10.
go back to reference Ilgen MA, Bohnert AS, Chermack S, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111(8):1385-1393.CrossRef Ilgen MA, Bohnert AS, Chermack S, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111(8):1385-1393.CrossRef
11.
go back to reference Kemp J, Bossarte RM. Surveillance of suicide and suicide attempts among veterans: addressing a national imperative. Am J Public Health. 2012;102 Suppl 1:e4-5.CrossRef Kemp J, Bossarte RM. Surveillance of suicide and suicide attempts among veterans: addressing a national imperative. Am J Public Health. 2012;102 Suppl 1:e4-5.CrossRef
12.
go back to reference Kerns RD, Philip EJ, Lee AW, Rosenberger PH. Implementation of the Veterans Health Administration National Pain Management Strategy. Transl Behav Med. 2011;1(4):635-643.CrossRef Kerns RD, Philip EJ, Lee AW, Rosenberger PH. Implementation of the Veterans Health Administration National Pain Management Strategy. Transl Behav Med. 2011;1(4):635-643.CrossRef
13.
go back to reference Kligler B, Bair MJ, Banerjea R, et al. Clinical policy recommendations from the VHA State-of-the-Art Conference on non-pharmacological approaches to chronic musculoskeletal pain. J Gen Intern Med. 2018;33(Suppl 1):16-23.CrossRef Kligler B, Bair MJ, Banerjea R, et al. Clinical policy recommendations from the VHA State-of-the-Art Conference on non-pharmacological approaches to chronic musculoskeletal pain. J Gen Intern Med. 2018;33(Suppl 1):16-23.CrossRef
14.
go back to reference Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Evidence brief: Barriers and facilitators to use of medications for opioid use disorder. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs, 2019. VA ESP Project #09-009. https://www.hsrd.research.va.gov/publications/esp/reports.cfm. Accessed 3 March 2020. Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Evidence brief: Barriers and facilitators to use of medications for opioid use disorder. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs, 2019. VA ESP Project #09-009. https://​www.​hsrd.​research.​va.​gov/​publications/​esp/​reports.​cfm. Accessed 3 March 2020.
15.
go back to reference Mackey K, Anderson J, Bourne D, Chen E, Peterson K. Evidence brief: Benefits and harms of long-term opioid dose reduction or discontinuation in patients with chronic pain. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs; 2019. VA ESP Project #09-199. Available at: https://www.hsrd.research.va.gov/publications/esp/reports.cfm. Accessed 3 Mar 2020. Mackey K, Anderson J, Bourne D, Chen E, Peterson K. Evidence brief: Benefits and harms of long-term opioid dose reduction or discontinuation in patients with chronic pain. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs; 2019. VA ESP Project #09-199. Available at: https://​www.​hsrd.​research.​va.​gov/​publications/​esp/​reports.​cfm. Accessed 3 Mar 2020.
16.
go back to reference Nahin RL. Severe Pain in Veterans: The effect of age and sex, and comparisons with the general population. J Pain. 2017;18(3):247-254.CrossRef Nahin RL. Severe Pain in Veterans: The effect of age and sex, and comparisons with the general population. J Pain. 2017;18(3):247-254.CrossRef
17.
19.
go back to reference Nevedal AL, Wagner TH, Ellerbe LS, Asch SM, Koenig CJ. A qualitative study of primary care providers’ experiences with the Veterans Choice Program. J Gen Intern Med. 2019;34(4):598-603.CrossRef Nevedal AL, Wagner TH, Ellerbe LS, Asch SM, Koenig CJ. A qualitative study of primary care providers’ experiences with the Veterans Choice Program. J Gen Intern Med. 2019;34(4):598-603.CrossRef
Metadata
Title
Implementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety
Authors
Joseph W. Frank, MD, MPH
Amy S. B. Bohnert, PhD, MHS
Friedhelm Sandbrink, MD
Marsden McGuire, MD, MBA
Karen Drexler, MD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue Special Issue 3/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06295-y

Other articles of this Special Issue 3/2020

Journal of General Internal Medicine 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.